Multiomic Health
  • home.
  • about.
  • focus.
  • approach.
  • news.
  • team.
  • investors.
  • contact.
  • careers.
24 May 2023 by Multiomic

A paper by the MultiOmic team members was published in the May issue of the ICT magazine

A paper by the MultiOmic team members was published in the May issue of the ICT magazine
24 May 2023 by Multiomic

PROGNOSTIC AND RESPONSE BIOMARKERS ARE THE FUTURE OF PRECISION NEPHROLOGY TRIALS

The May issue of the International Clinical Trials (ICT) magazine was published today!

In this issue is also a paper written by MultiOmic’s Business Development Associate Rebecca Cripps and it’s CEO Robert Thong addressing the question of 

“what insight can recent trials give us into how molecular-level disease drivers can be used to enter into a new era of precision nephrology?”

Read the full article here.

Previous articleMultiOmic Health Closes $6.2 Million Funding Round to Discover Precision Medicines for Metabolic Syndrome-Related Conditions

About Multiomic

Multiomic is a next-generation precision medicine business, applying computational systems biology to develop and commercialize data assets for metabolic syndrome — the world’s largest healthcare burden.

With our unique combination of data science and biology expertise, we are enabling data-driven development of therapeutics and are bringing understanding into complex biological systems.

Recent Posts

A paper by the MultiOmic team members was published in the May issue of the ICT magazine24 May 2023
MultiOmic Health Closes $6.2 Million Funding Round to Discover Precision Medicines for Metabolic Syndrome-Related Conditions4 May 2023
MultiOmic Health forges research collaboration with Northern Care Alliance NHS Foundation Trust in diabetic kidney disease6 December 2022

Categories

  • Articles
  • Blog Post
  • Interview
  • News
  • News from the Team
  • Podcast
  • Press Release

Tags

AI BIA Biomarkers CKD Clinical Trials Conference Drug Discovery Feature Fundraising ICT Mesh Bio Metabolic Syndrome MOHSAIC Multiomic Health Nature NCA Nephrology Omics Partnership Podcast Precision Medicine Press Release Robert Thong TechBio UK The Pharma Letter

About

Multiomic Health Limited is a next-generation precision medicine business, applying computational systems biology to develop  and commercialize data assets for metabolic syndrome

Contact

info@multiomic.healthhttps://multiomic.health/
Multiomic Health Limited. All Rights Reserved.

© Multiomic Health Limited 2021. All Rights Reserved.

Multiomic Health Limited is a Registered UK Company

Company Number: 13246608

Company Address: Epworth House, 25 City Road, Shoreditch, London, EC1Y 1AA

CONTACT

info@multiomic.health

COPYRIGHT notice

All the content on multiomic.health is either self-generated by Multiomic Health Limited, or readily available in various places on the Internet and therefore believed to be in the public domain. Transparent PNG images uploaded are believed to be posted within our rights according to the U.S. Copyright Fair Use Act (Title 17, U.S. Code.) and comparable regulations in other countries.

multiomic.health complies with 17 U.S.C. 512 and the Digital Millennium Copyright Act (“DMCA”). It is our policy to respond to any infringement notices and take appropriate actions under the DMCA and other applicable intellectual property laws.

If by any chance your copyrighted material has been posted on multiomic.health or if links to your copyrighted material are returned through a search engine and you wish this material removed, please provide a written statement identifying in sufficient detail the copyrighted work claimed to have been infringed. You may use the contact form at the end of the landing page for the purposes of such written communication.

 

DATA SOURCES

https://ourworldindata.org/causes-of-death

https://ourworldindata.org/obesity

https://bmjopen.bmj.com/content/10/8/e036663

How Prevalent is NASH?

https://www.heart.org/-/media/phd-files-2/science-news/2/2021-heart-and-stroke-stat-update/2021_heart_disease_and_stroke_statistics_update_fact_sheet_at_a_glance.pdf?la=en

https://www.ahajournals.org/doi/10.1161/CIR.0000000000000757

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278808/

https://www.cdc.gov/obesity/data/adult.html

https://stop.publichealth.gwu.edu/sites/stop.publichealth.gwu.edu/files/documents/Fast%20Facts%20Cost%20of%20Obesity.pdf

https://www.sciencedirect.com/science/article/abs/pii/S2211883717300187

https://journals.lww.com/jcge/Abstract/2015/09000/The_Epidemiology_of_Cirrhosis_in_the_United.12.aspx#:~:text=The%20prevalence%20of%20cirrhosis%20in%20the%20United%20States%20was%20approximately,unaware%20of%20having%20liver%20disease

How Prevalent is NASH?

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743497/#:~:text=In%20the%20United%20States%2C%20NAFLD,nearly%2025%25%20progress%20to%20NASH

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767767/

https://www.nature.com/articles/nrgastro.2017.109

https://www.diabetes.org/resources/statistics/statistics-about-diabetes#:~:text=Prevalence%3A%20In%202018%2C%2034.2%20million,of%20the%20population%2C%20had%20diabetes.&text=Undiagnosed%3A%20Of%20the%2034.2%20million,and%207.3%20million%20were%20undiagnos

https://www.kcl.ac.uk/news/spotlight/global-cost-of-diabetes-set-to-double-by-2030

https://www.kcl.ac.uk/news/spotlight/global-cost-of-diabetes-set-to-double-by-2030

https://www.worldobesity.org/news/world-obesity-day-all-countries-significantly-off-track-to-meet-2025-who-targets-on-obesity